Search Results - "KONG, Sheldon X"

Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set by Pantalone, Kevin M, Misra-Hebert, Anita D, Hobbs, Todd M, Ji, Xinge, Kong, Sheldon X, Milinovich, Alex, Weng, Wayne, Bauman, Janine, Ganguly, Rahul, Burguera, Bartolome, Kattan, Michael W, Zimmerman, Robert S

“…Pantalone et al. discussed the evidence of clinical inertia in type 2 diabetes (T2D) management according to a large, real-world data set. A systematic review…”
Get full text

Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? by Eichler, Hans-Georg, Kong, Sheldon X., Gerth, William C., Mavros, Panagiotis, Jönsson, Bengt

“…An increasing number of health-care systems, both public and private, such as managed-care organizations, are adopting results from cost-effectiveness (CE)…”
Get full text

The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States by Weng, Wayne, Tian, Ye, Kong, Sheldon X., Ganguly, Rahul, Hersloev, Malene, Brett, Jason, Hobbs, Todd

“…Objectives The purpose of this study was to assess atherosclerotic cardiovascular disease (ASCVD) prevalence, antidiabetes medication usage and physician…”
Get full text

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease by Pantalone, Kevin M, Misra-Hebert, Anita D, Hobbs, Todd M, Ji, Xinge, Kong, Sheldon X, Milinovich, Alex, Weng, Wayne, Bauman, Janine, Ganguly, Rahul, Burguera, Bartolome, Kattan, Michael W, Zimmerman, Robert S

“…To evaluate real-world patient characteristics, medication use, and health care utilization patterns in patients with type 2 diabetes with established…”
Get full text

Quantifying the economic burden of unintended pregnancies due to drug-drug interactions with hormonal contraceptives from the United States payer perspective by Srinivasan, Meenakshi, White, Annesha, Lott, Jason, Williamson, Todd, Kong, Sheldon X, Plouffe, Leo

“…In the United States of America (USA), nearly 10 million women use oral contraceptives (OCs). Concomitant administration of certain medications can result in…”
Get full text

The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real‐world population with type 2 diabetes by Weng, Wayne, Kong, Sheldon X., Ganguly, Rahul, Hersloev, Malene, Brett, Jason, Hobbs, Todd, Baeres, Florian M.M.

“…Introduction The purpose of this study was to assess prevalence of atherosclerotic cardiovascular disease (ASCVD) according to number of affected vascular beds…”
Get full text

Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting by Weng, Wayne, Tian, Ye, Kong, Sheldon X, Ganguly, Rahul, Hersloev, Malene, Brett, Jason, Hobbs, Todd

“…This study evaluated the impact of atherosclerotic cardiovascular disease (ASCVD) on healthcare resource utilization and costs in patients with type 2 diabetes…”
Get full text

A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain by Schnitzer, Thomas J, Ferraro, Aimee, Hunsche, Elke, Kong, Sheldon X

“…A systematic review involving 50 randomized controlled trials (4,863 patients) published since 1980 was undertaken with the objective of assessing efficacy and…”
Get full text

Prescription of guideline‐directed medical therapies in patients with diabetes and chronic kidney disease from the CURE‐CKD Registry, 2019‐2020 by Nicholas, Susanne B., Daratha, Kenn B., Alicic, Radica Z., Jones, Cami R., Kornowske, Lindsey M., Neumiller, Joshua J., Fatoba, Samuel T., Kong, Sheldon X., Singh, Rakesh, Norris, Keith C., Tuttle, Katherine R.

“…Aim Guideline‐directed medical therapy (GDMT) is designed to improve clinical outcomes. The study aim was to assess GDMT prescribing rates and…”
Get full text

Persistence of newer anti-obesity medications in a real-world setting by Ganguly, Rahul, Tian, Ye, Kong, Sheldon X., Hersloev, Malene, Hobbs, Todd, Smolarz, B. Gabriel, Ramasamy, Abhilasha, Haase, Christiane Lundegaard, Weng, Wayne

“…Evaluate real-world data on persistence with anti-obesity medications (AOMs) and explore associated patient factors. Truven Health MarketScan® data were…”
Get full text

Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system by Pantalone, Kevin M, Hobbs, Todd M, Chagin, Kevin M, Kong, Sheldon X, Wells, Brian J, Kattan, Michael W, Bouchard, Jonathan, Sakurada, Brian, Milinovich, Alex, Weng, Wayne, Bauman, Janine, Misra-Hebert, Anita D, Zimmerman, Robert S, Burguera, Bartolome

“…ObjectiveTo determine the prevalence of obesity and its related comorbidities among patients being actively managed at a US academic medical centre, and to…”
Get full text

Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease by Lamprea-Montealegre, Julio A, Madden, Erin, Tummalapalli, Sri Lekha, Chu, Chi D, Peralta, Carmen A, Du, Yuxian, Singh, Rakesh, Kong, Sheldon X, Tuot, Delphine S, Shlipak, Michael G, Estrella, Michelle M

“…To assess the prevalence and correlates of prescription of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and/or glucagon-like peptide 1 receptor agonists…”
Get full text

Medical costs for managing chronic kidney disease and related complications in patients with chronic kidney disease and type 2 diabetes by Betts, Keith A, Song, Jinlin, Faust, Elizabeth, Yang, Karen, Du, Yuxian, Kong, Sheldon X, Singh, Rakesh

“…To provide cost estimates for chronic kidney disease (CKD) management and major CKD complications among patients with CKD and type 2 diabetes (T2D). A…”
Get full text

The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model by Pantalone, Kevin M, Misra-Hebert, Anita D, Hobbs, Todd M, Kong, Sheldon X, Ji, Xinge, Ganguly, Rahul, Milinovich, Alex, Weng, Wayne, Bauman, Janine M, Petraro, Paul, Burguera, Bartolome, Zimmerman, Robert S, Kattan, Michael W

“…To assess patient characteristics and treatment factors associated with uncontrolled type 2 diabetes (T2D) and the probability of hemoglobin A (A1C) goal…”
Get full text

Poor adherence to clinical practice guidelines: A call to action for increased albuminuria testing in patients with type 2 diabetes by Williamson, Todd, Gomez-Espinosa, Evelyn, Stewart, Fiona, Dean, Bonnie B., Singh, Rakesh, Cui, Jingsong, Kong, Sheldon X.

“…We describe the substantial shortfall in adherence to guideline-recommended albumin-to-creatinine ratio (uACR) testing for people in the United States with…”
Get full text

Changes in Characteristics and Treatment Patterns of Patients with Newly Diagnosed Type 2 Diabetes in a Large United States Integrated Health System between 2008 and 2013 by Pantalone, Kevin M., Hobbs, Todd M., Wells, Brian J., Kong, Sheldon X., Kattan, Michael W., Bouchard, Jonathan, Chagin, Kevin M., Yu, Changhong, Sakurada, Brian, Milinovich, Alex, Weng, Wayne, Bauman, Janine M., Zimmerman, Robert S.

“…To assess changes in the clinical characteristics and treatment patterns of patients with newly diagnosed type 2 diabetes (T2D), the electronic health record…”
Get full text

Drug–drug interaction potential among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with novel androgen receptor inhibitors by Appukkuttan, Sreevalsa, Ko, Gilbert, Fu, Chunmay, Bannister, Breyanne, Kong, Sheldon X., Jhaveri, Jay, Freedland, Stephen J.

Get full text

Adverse events and costs among non-metastatic castration-resistant prostate cancer patients by Appukkuttan, Sreevalsa, Yao, Jianying, Partridge, Jamie, Kong, Sheldon X, Parkin, Jacqueline, Freedland, Stephen J

“…Limited real-world evidence exists on the economic burden of adverse events (AEs) to the healthcare system among patients with non-metastatic…”
Get more information

Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database by Wanner, Christoph, Schuchhardt, Johannes, Bauer, Chris, Lindemann, Stefanie, Brinker, Meike, Kong, Sheldon X., Kleinjung, Frank, Horvat-Broecker, Andrea, Vaitsiakhovich, Tatsiana

“…Background The observational, real-world evidence FLIEDER study aimed to describe patient clinical characteristics and investigate clinical outcomes in…”
Get full text

Risk of chronic kidney disease in patients with acute kidney injury following a major surgery: a US claims database analysis by Ohlmeier, Christoph, Schuchhardt, Johannes, Bauer, Chris, Brinker, Meike, Kong, Sheldon X, Scott, Charlie, Vaitsiakhovich, Tatsiana

“…Background Acute kidney injury (AKI) is a common complication after major surgery. This study assessed the risk of developing or worsening of chronic kidney…”
Get full text